Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate the global incidence of the endometrial changes in postmenopausal women receiving Anastrozole for the adjuvant treatment of hormone receptors positive breast cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Women with hormone receptor positive breast cancer under adjuvant treatment with Anastrozole |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Global incidence of endometrial changes during the adjuvant treatment with Anastrozole | From inclusion to treatment end(5 years duration) measurements will be taken annually, with a further assessment 12 months after end of treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| To describe the endometrial changes both clinically(vaginal bleeding) and through the scan. | During the study, at least annually | |
| Histological assessment when indicated(type of hyperplasia) | When applicable |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Medical Oncology
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rosana Cajal, MD | AstraZeneca Spain | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | A Coruña | Spain | ||||
| Research Site |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| To assess global incidence of endometrial changes in this patient population before taking Anastrozole | During the study |
| To evaluate type of surgery required for endometrial changes control(hysterectomy rate) | During the study |
| To assess treatment tolerability | During the study |
| Granada |
| Spain |
| Research Site | Huelva | Spain |
| Research Site | Ibiza Town | Spain |
| Research Site | Jerez de la Frontera | Spain |
| Research Site | La Rioja | Spain |
| Research Site | Lugo | Spain |
| Research Site | Mallorca | Spain |
| Research Site | Málaga | Spain |
| Research Site | Pontevedra | Spain |
| Research Site | Santander | Spain |
| Research Site | Seville | Spain |
| D017437 |
| Skin and Connective Tissue Diseases |